Rapid cognitive decline in Alzheimer's disease. Consensus paper
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
The rate of cognitive decline in Alzheimer's disease (AD) varies considerably between individuals, with some subjects showing substantial deterioration and others showing little or no change over the course of the disease. These wide variations support the relatively new concept of Rapid Cognitive Decline (RCD). Patients with an accelerated rate of cognitive decline have showed to present a worse evolution in terms of mortality, loss of autonomy and institutionalisation. The conclusions from RCD studies conducted in the past years remain very heterogeneous and sometimes contradictory. This is possibly due to methodological differences, mainly the different "a priori" definitions of RCD used to identify rapid decliners. Consequently of this, there is considerable variation in reported frequency of patients with RCD which may vary from 9.5% to 54%. The lack of both consensus definition and consensual clinical assessment tools is one of the major barriers for establishing an appropriated management of rapid decliners in clinical practice. Presently, management of rapid decliners in AD remains to be a challenge waiting to better know predictive factors of a RCD. To date no specific guidelines exist to follow-up or to treat patients with this condition. This consensus paper proposes the loss of 3 points or greater in Mini-Mental State Examination (MMSE) during six months as an empirical definition of rapid cognitive decline to be used in routine medical practice and to be relevant for clinical-decision making in patients with mild to moderately-severe AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kok, J. S., Berg, I. J., & Scherder, E. J. A. (2013) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000353441 · Cited by 20,589
Smoking as a Risk Factor for Dementia and Cognitive Decline: A Meta-Analysis of Prospective Studies
Anstey, K. J., von Sanden, C., Salim, A., & O'Kearney, R. (2007) · American Journal of Epidemiology · doi:10.1093/aje/kwm116 · Cited by 921
Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD
Jack, C. R., Shiung, M. M., Gunter, J. L., O’Brien, P. C., Weigand, S. D., Knopman, D. S., Boeve, B. F., Ivnik, R. J., Smith, G. E., Cha, R. H., et al. (2004) · Neurology · doi:10.1212/01.wnl.0000110315.26026.ef · Cited by 827 · cited 1×
“…Jr et al, found that the atrophy rates (hippocampus, entorhinal cortex, whole brain and ventricle) were greater among fast than slow AD progressors (60) According to this, Kinkingnéhun et al, in 2008 aimed to determine whether regional atrophy could predict the rate of decline in patients with…”
Inverse relationship between education and parietotemporal perfusion deficit in Alzheimer's disease
Stern, Y., Alexander, G. E., Prohovnik, I., & Mayeux, R. (1992) · Annals of Neurology · doi:10.1002/ana.410320311 · Cited by 470
Clark, C. M. (1999) · Archives of Neurology · doi:10.1001/archneur.56.7.857 · Cited by 298
Jacobs, D., Sano, M., Marder, K., Bell, K., Bylsma, F., Lafleche, G., Albert, M., Brandt, J., & Stern, Y. (1994) · Neurology · doi:10.1212/wnl.44.7.1215 · Cited by 266
Education delays accelerated decline on a memory test in persons who develop dementia
Hall, C. B., Derby, C., LeValley, A., Katz, M. J., Verghese, J., & Lipton, R. B. (2007) · Neurology · doi:10.1212/01.wnl.0000278163.82636.30 · Cited by 257
APOE ε4 allele predicts faster cognitive decline in mild Alzheimer disease
Cosentino, S., Scarmeas, N., Helzner, E., Glymour, M. M., Brandt, J., Albert, M., Blacker, D., & Stern, Y. (2008) · Neurology · doi:10.1212/01.wnl.0000304038.37421.cc · Cited by 214
APOE alleles predict the rate of cognitive decline in Alzheimer disease: A nonlinear model
Martins, C. A. R., Oulhaj, A., de Jager, C. A., & Williams, J. H. (2005) · Neurology · doi:10.1212/01.wnl.0000188871.74093.12 · Cited by 205
Measurement and prediction of functional capacity in Alzheimer's disease
Stern, Y., Hesdorffer, D., Sano, M., & Mayeux, R. (1990) · Neurology · doi:10.1212/wnl.40.1.8 · Cited by 147
Cognitive decline in Alzheimer disease: Impact of spirituality, religiosity, and QOL
Kaufman, Y., Anaki, D., Binns, M., & Freedman, M. (2007) · Neurology · doi:10.1212/01.wnl.0000260697.66617.59 · Cited by 109
Outcome of Alzheimer's disease: potential impact of cholinesterase inhibitors
Gillette-Guyonnet, S., Andrieu, S., Cortes, F., Nourhashemi, F., Cantet, C., Ousset, P.-J., Reynish, E., Grandjean, H., & Vellas, B. (2006) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/61.5.516 · Cited by 41
Cited by
Caffeine Intake is Associated with a Lower Risk of Cognitive Decline: A Cohort Study from Portugal
Santos, C., Lunet, N., Azevedo, A., de Mendonça, A., Ritchie, K., & Barros, H. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-091303 · Cited by 100
“A consensus paper recently published suggested that a decrease of 3 or more points in MMSE for a period of six months could be used to define rapid cognitive decline in patients with mild to moderately severe AD [42], and it is reasonable to assume that it corresponds to a clinically meaningful deterioration also in s…”
Long-term progression of Alzheimer's disease in patients under antidementia drugs
Gillette‐Guyonnet, S., Andrieu, S., Nourhashemi, F., Gardette, V., Coley, N., Cantet, C., Gauthier, S., Ousset, P., Vellas, B., & REAL.FR study group (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.02.009 · Cited by 64
Self-citationCognitive Decline in Alzheimer’s Disease Is Not Associated with APOE
Katzourou, I., Initiative, T. A. D. N., Leonenko, G., Ivanov, D., Meggy, A., Marshall, R., Sims, R., Williams, J., Holmans, P., & Escott-Price, V. (2021) · Journal of Alzheimer's Disease · doi:10.3233/jad-210685 · Cited by 9
“TheseresultsareillustratedinSupplemen-tary Figure 3.”
Influential
Metadata
- Authors
- Soto, M. E., Andrieu, S., Arbus, C., Ceccaldi, M., Couratier, P., Dantoine, T., Dartigues, J. F., Gillette-guyonette, S., Nourhashemi, F., Ousset, P. J., Poncet, M., Portet, F., Touchon, J., & Vellas, B.
- Venue
- The Journal of nutrition, health and aging
- Publisher
- Elsevier BV
- Published
- 2008-12
- Volume
- 12
- Issue
- 10
- Pages
- 703-713
- ISSN
- 1279-7707 (ISSN-L)
- OpenAlex
- W2100557711
- Cited by
- 82
- References
- 12
- FWCI
- 2.30
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.